ATE282608T1 - Chinoxalindionen - Google Patents

Chinoxalindionen

Info

Publication number
ATE282608T1
ATE282608T1 AT98913660T AT98913660T ATE282608T1 AT E282608 T1 ATE282608 T1 AT E282608T1 AT 98913660 T AT98913660 T AT 98913660T AT 98913660 T AT98913660 T AT 98913660T AT E282608 T1 ATE282608 T1 AT E282608T1
Authority
AT
Austria
Prior art keywords
preparation
quinoxalindiones
solvate
compounds
processes
Prior art date
Application number
AT98913660T
Other languages
English (en)
Inventor
Alan Stobie
Elisabeth Colette Loui Gautier
David Charles Waite
Robert James Crook
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1997/000995 external-priority patent/WO1997032873A1/en
Priority claimed from GBGB9715783.8A external-priority patent/GB9715783D0/en
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE282608T1 publication Critical patent/ATE282608T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT98913660T 1997-02-27 1998-02-24 Chinoxalindionen ATE282608T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP1997/000995 WO1997032873A1 (en) 1996-03-09 1997-02-27 Quinoxalinediones
GBGB9715783.8A GB9715783D0 (en) 1997-02-27 1997-07-25 Quinoxalinediones
PCT/EP1998/001275 WO1998038186A1 (en) 1997-02-27 1998-02-24 Quinoxalinediones

Publications (1)

Publication Number Publication Date
ATE282608T1 true ATE282608T1 (de) 2004-12-15

Family

ID=26070194

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98913660T ATE282608T1 (de) 1997-02-27 1998-02-24 Chinoxalindionen

Country Status (16)

Country Link
EP (1) EP0973766B1 (de)
JP (2) JP3588363B2 (de)
CN (2) CN1121403C (de)
AT (1) ATE282608T1 (de)
BG (1) BG103685A (de)
BR (1) BR9808126A (de)
CA (1) CA2281580C (de)
DE (1) DE69827614T2 (de)
ES (1) ES2230685T3 (de)
HR (1) HRP980104A2 (de)
HU (1) HUP0003612A3 (de)
NO (1) NO994135L (de)
NZ (1) NZ336842A (de)
SK (1) SK113399A3 (de)
TR (1) TR199902055T2 (de)
WO (1) WO1998038186A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9605027D0 (en) * 1996-03-09 1996-05-08 Pfizer Ltd Quinoxalinediones
GB0310881D0 (en) * 2003-05-12 2003-06-18 Merck Sharp & Dohme Pharmaceutical formulation
MY145368A (en) 2004-01-13 2012-01-31 Nissan Chemical Ind Ltd Aminoquinoxaline compounds and polyaminoquinoxaline compounds, and use thereof
EP1713101B1 (de) 2004-02-06 2012-10-31 Yamaguchi University Elektrode für eine energiespeichereinrichtung und herstellungsprozess dafür
EP2044066A2 (de) * 2006-06-06 2009-04-08 Bristol-Myers Squibb Company Kristalline formen von n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidincarbonsäureamid
CN101679383B (zh) 2007-05-17 2014-10-29 株式会社半导体能源研究所 三唑衍生物，和使用三唑衍生物的发光元件、发光器件和电子器件
WO2011051478A1 (en) * 2009-10-30 2011-05-05 Domain Therapeutics Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE194985T1 (de) * 1990-11-06 2000-08-15 Yamanouchi Pharma Co Ltd Kondensiertes pyrazinderivat
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
GB9605027D0 (en) * 1996-03-09 1996-05-08 Pfizer Ltd Quinoxalinediones

Also Published As

Publication number Publication date
HUP0003612A3 (en) 2003-04-28
JP2000509730A (ja) 2000-08-02
TR199902055T2 (xx) 2000-07-21
BR9808126A (pt) 2000-03-08
CN1443763A (zh) 2003-09-24
NO994135D0 (no) 1999-08-26
CA2281580C (en) 2003-04-22
HRP980104A2 (en) 1999-02-28
EP0973766B1 (de) 2004-11-17
DE69827614T2 (de) 2005-11-10
WO1998038186A1 (en) 1998-09-03
JP3588363B2 (ja) 2004-11-10
DE69827614D1 (de) 2004-12-23
SK113399A3 (en) 2001-04-09
CN1121403C (zh) 2003-09-17
CN1248971A (zh) 2000-03-29
NO994135L (no) 1999-10-22
NZ336842A (en) 2000-05-26
HUP0003612A2 (hu) 2001-10-28
EP0973766A1 (de) 2000-01-26
BG103685A (bg) 2000-06-30
ES2230685T3 (es) 2005-05-01
CA2281580A1 (en) 1998-09-03
JP2004269547A (ja) 2004-09-30

Similar Documents

Publication Publication Date Title
YU41199A (sh) Hinoksalindioni
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
DE69831868D1 (en) Antithrombosemittel
ATE297203T1 (de) Antithrombotische mitteln
BR0210078A (pt) Composto, uso do mesmo, e, formulação farmacêutica
BR9303993A (pt) Composto, processo para preparar o mesmo e composição farmacêutica
EA199900373A2 (ru) Фармацевтические композиции
NO20006323D0 (no) Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse
MY119820A (en) Guanidine mimics as factor xa inhibitors
AU2003228770A1 (en) Substituted pyrazolopyrimidines
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
PH30006A (en) 9-¬(Substituted glycol)amido¾-6.demethyl-6-deoxytetra-cyclines
MY124078A (en) Eletriptan hydrobromide monohydrate
DE69330601D1 (de) Serotoninergische ergolin derivate
DE60201074D1 (en) Pyrazolopyridinderivate
DE69827614D1 (de) Chinoxalindionen
EA200100984A1 (ru) Новые кристаллические формы макролидного антибиотика
WO2003080631A8 (en) Plasma carboxypeptidase b inhibitors
SE9904128D0 (sv) Novel compounds
MY129094A (en) Condensed polycyclic compounds
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
EA199900688A1 (ru) Хиноксалиндионы
YU82302A (sh) Derivati 2-aminokarbonil-9h-purina
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties